<p>(A) Bodyweights of the bilirubin-treated rats and control rats on PMDs-1/2/3. (B) Bodyweight gains of the bilirubin-treated rats and control rats on PMDs-1/2/3. (C) Bodyweight gains of the bilirubin-treated rats and control rats on PWDs-1/2/3. (n = 12 in each group). *: <i>P</i><0.01 vs control group. (PMD: post-modeling day; PWD: post-weaning day).</p
<p>Each value is expressed as mean ±SD (n = 10). Significance difference between control and treatme...
<p>The animals were pretreated with probucol (3.5 mg/kg/day) or vehicle (1% of DMSO) in drinking wat...
<p><b>(A)</b> Caloric intake was assessed at various time points of MnTBAP treatment in mice previou...
<p>(A) Study design. (B) Mean liver weight for each experimental group at week 4 before PHx (left pa...
<p>A, body weight of rats in the whole experimental period; B, increased body weight ratio of treatm...
<p>Data are presented as means ± SEM for 8 rats in each group. **P<0.01, statistically significant c...
(A-D) Physiological parameters. (A) Body weight change. The percentage change in body weight from th...
<p>* denotes significant difference between olanzapine and control group at P<0.05; # denotes signif...
<p>Body weight gain (increment from day 0) in rats after nesfatin-1 injection (15, 25, or 50 pmol da...
<p>Body weight measurements from vehicle (aging) control (CON), Sal B40 mg/kg/d alone (B40), prednis...
<p>ΔW-Con: weight gain in the control groups. ΔW-Cef: weight gain in the cefdinir-treated groups. ΔW...
<p>CD: CD rats, BH: BH rats. c: saline-injected, DXR: Doxorubicin-injected rats (5 mg/kg). *: p<0.05...
<p>A) Body weight measurements of adult control mice or mice treated with 1NMPP1 at four months of a...
<p>Effect of 10 weeks DMH treatment followed by DOX for 15 days on body weights of rats.</p
Body weight gain (% difference in body weight compared to body weight on Day 1, mean value ± standar...
<p>Each value is expressed as mean ±SD (n = 10). Significance difference between control and treatme...
<p>The animals were pretreated with probucol (3.5 mg/kg/day) or vehicle (1% of DMSO) in drinking wat...
<p><b>(A)</b> Caloric intake was assessed at various time points of MnTBAP treatment in mice previou...
<p>(A) Study design. (B) Mean liver weight for each experimental group at week 4 before PHx (left pa...
<p>A, body weight of rats in the whole experimental period; B, increased body weight ratio of treatm...
<p>Data are presented as means ± SEM for 8 rats in each group. **P<0.01, statistically significant c...
(A-D) Physiological parameters. (A) Body weight change. The percentage change in body weight from th...
<p>* denotes significant difference between olanzapine and control group at P<0.05; # denotes signif...
<p>Body weight gain (increment from day 0) in rats after nesfatin-1 injection (15, 25, or 50 pmol da...
<p>Body weight measurements from vehicle (aging) control (CON), Sal B40 mg/kg/d alone (B40), prednis...
<p>ΔW-Con: weight gain in the control groups. ΔW-Cef: weight gain in the cefdinir-treated groups. ΔW...
<p>CD: CD rats, BH: BH rats. c: saline-injected, DXR: Doxorubicin-injected rats (5 mg/kg). *: p<0.05...
<p>A) Body weight measurements of adult control mice or mice treated with 1NMPP1 at four months of a...
<p>Effect of 10 weeks DMH treatment followed by DOX for 15 days on body weights of rats.</p
Body weight gain (% difference in body weight compared to body weight on Day 1, mean value ± standar...
<p>Each value is expressed as mean ±SD (n = 10). Significance difference between control and treatme...
<p>The animals were pretreated with probucol (3.5 mg/kg/day) or vehicle (1% of DMSO) in drinking wat...
<p><b>(A)</b> Caloric intake was assessed at various time points of MnTBAP treatment in mice previou...